Dive Brief: Katrine Bosley, the former CEO of gene editing biotech company Editas Medicine, has joined U.K.-based Advent Life Sciences as a venture partner, the …
One week after placing CEO Clay Siegall on leave, cancer drug developer Seagen announced Monday that its cofounder and longtime leader has resigned as he …
Dive Brief: Fresh off the dedication of a major new building in Boston’s Seaport, Vertex Pharmaceuticals said it’s making plans for yet another facility that …
Biogen is searching for a new CEO along with additional ways to cut costs after another quarter of paltry sales for its closely watched Alzheimer’s …
Dive Brief: Adagio Therapeutics CEO Tillman Gerngross has agreed “in principle” to resign as head of the COVID-19 drug developer amid confusion over whether its …
Jeffrey Marrazzo, CEO of gene therapy developer Spark Therapeutics, will step down as head of the company he co-founded almost nine years ago, steered to …
Brief: Allergan CEO Brent Saunders said Monday the Irish pharma is considering a wide range of business options, including further divestitures or a split of …
